Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection

Hepatology

Volumn 49, Issue 3, 2009, Pages 781-790

  Pati, Nirupma Trehan ^a,b,d   Geffers, Robert ^b   Sukriti, ^a,b   Hissar, Syed ^a   Riese, Peggy ^b   Toepfer, Tanja ^b   Buer, Jan ^c   Kumar, Manoj ^a,d   Guzman, Carlos A ^b   Sarin, Shiv Kumar ^a,d  

^a G B PANT HOSPITAL   (India)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR8; MITOGEN ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; CHEMOKINE; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE KINASE;

ACUTE HEPATITIS; ADULT; APOPTOSIS; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ADHESION; CELL FUNCTION; CELL PROLIFERATION; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA FINGERPRINTING; SIGNAL TRANSDUCTION; ACUTE DISEASE; ADOLESCENT; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; GENETICS; METABOLISM; PATHOLOGY;

ACUTE DISEASE; ADOLESCENT; ADULT; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHEMOKINES; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; HEPATITIS B; HEPATITIS B, CHRONIC; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 63349104604     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22696     Document Type: Article

References (51)

1. Kane MA. World-wide epidemiology of hepatitis B [in French, German]. Soz Praventivmed 1998;43(Suppl 1):S24-S26.
2. Thursz M. Genetic susceptibility in chronic viral hepatitis. Antiviral Res 2001; 52:113-116.
3. Thursz MR. Host genetic factors influencing the outcome of hepatitis. J Viral Hepat 1997;4:215-220.
4. Okabe H, Satoh S, Kato T, Osamu K, Yanagawa R, Yamaoka Y, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: Identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001;61:2129-2137.
5. Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, et al. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. Int J Oncol 2006;29:315-327.
6. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005;5:215-229.
7. Lin CY, Tsai MC, Huang CT, Hsu CW, Tseng SC, Tsai IF, et al. Liver injury is associated with enhanced regulatory T-cell activity in patients with chronic hepatitis B. J Viral Hepat 2007;14:503-511.
8. Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 2008;123:57-65.
9. Rushbrook SM, Ward SM, Unitt E, Vowler SL, Lucas M, Klenerman P, et al. Regulatory T cells suppress in vitro proliferation of virus-specific CD8+T cells during persistent hepatitis C virus infection. J Virol 2005; 79:7852-7859.
10. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. HEPATOLOGY 2005;41:771-778.
11. Stoop JN, van der Molen RG, Kuipers EJ, Kusters JG, Janssen HL. Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B. Virology 2007;361:141-148.
12. Belkaid Y. Regulatory T cells and infection: A dangerous necessity. Nat Rev Immunol 2007;7:875-888.
13. Mills KH. Regulatory T cells: Friend or foe in immunity to infection? Nat Rev Immunol 2004;4:841-855.
14. +) T cells by regulatory T cells during persistent retroviral infection. Immunity 2004;20:293-303.
15. Zelinskyy G, Kraft AR, Schimmer S, Arndt T, Dittmer U. Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection. Eur J Immunol 2006;36: 2658-2670.
16. Pfoertner S, Jeron A, Probst-Kepper M, Guzman CA, Hansen W, Westendorf AM, et al. Signatures of human regulatory T cells: An encounter with old friends and new players. Genome Biol 2006;7:R54.
17. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990;9:811-818.
18. Sturn A, Quackenbush J, Trajanoski Z. Genesis: Cluster analysis of microarray data. Bioinformatics 2002;18:207-208.
19. Diehn M, Sherlock G, Binkley G, Jin H, Matese JC, Hernandez-Boussard T, et al. SOURCE: A unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res 2003;31:219-223.
20. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR. MAPPFinder: Using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 2003; 4:R7.
21. Salomonis N, Hanspers K, Zambon AC, Vranizan K, Lawlor SC, Dahlquist KD, et al. GenMAPP 2: New features and resources for pathway analysis. BMC Bioinformatics 2007;8:217.
22. Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006;177:739-747.
23. Suzuki N, Nuss DL. Contribution of protein p40 to hypovirus-mediated modulation of fungal host phenotype and viral RNA accumulation. J Virol 2002;76:7747-7759.
24. Bell SP, Dutta A. DNA replication in eukaryotic cells. Annu Rev Biochem 2002;71:333-374.
25. Basile Saint de G, Geissmann F, Flori E, Uring-Lambert B, Soudais C, Cavazzana-Calvo M, Durandy A, et al. Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3. J Clin Invest 2004;114:1512-1517.
26. Eleftheriadis T, Kartsios C, Yiannaki E, Kazila P, Antoniadi G, Liakopoulos V, et al. Chronic inflammation and T cell zeta-chain downregulation in hemodialysis patients. Am J Nephrol 2008;28:152-157.
27. Miceli MC, Parnes JR. Role of CD4 and CD8 in T cell activation and differentiation. Adv Immunol 1993;53:59-122.
28. Weckbecker G, Bruns C, Fischer KD, Heusser C, Li J, Metzler B, et al. Strongly reduced alloreactivity and long-term survival times of cardiac allografts in Vav1- and Vav1/Vav2-knockout. Transplant Inter 2007;20: 353-364.
29. Kimbara N, Dohi N, Miyamoto M, Asai S, Okada H, Okada N. Diagnostic surface expression of SWAP-70 on HIV-1 infected T cells. Microbiol Immunol 2006;50:235-242.
30. Johnson LA, Clasper S, Holt AP, Lalor PF, Baban D, Jackson DG. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med 2006;203:2763-2777.
31. Yatsula B, Galvao C, McCrann M, Perkins AS. Assessment of F-MuLV-induced tumorigenesis reveals new candidate tumor genes including Pecam1, St7, and Prim2. Leukemia 2006;20:162-165.
32. Madson JG, Lynch DT, Tinkum KL, Putta SK, Hansen LA. Erbb2 regulates inflammation and proliferation in the skin after ultraviolet irradiation. Am J Pathol 2006;169:1402-1414.
33. Zhou BP, Hung MC. Dysregulation of cellular signaling by HER2/neu in breast cancer. Semin Oncol 2003;30:38-48.
34. Mochizuki T, Kitanaka C, Noguchi K, Sugiyama A, Kagaya A, Chi S, et al. Pim-1 kinase stimulates c-Myc-mediated death signaling upstream of caspase-3 (CPP32)-like protease activation. Oncogene 1997;15:1471-1480.
35. Attisano L, Labbé E. TGFbeta and Wnt pathway cross-talk. Cancer Metastasis Rev 2004;23:53-61.
36. Sheppard D. Integrin-mediated activation of latent transforming growth factor beta. Cancer Metastasis Rev 2006;24:395-402.
37. Pritchard MT, Roychowdhury S, McMullen MR, Guo L, Arteel GE, Nagy LE. Early growth response-1 contributes to galactosamine/ lipopolysaccharide-induced acute liver injury in mice. Am J Physiol Gastrointest Liver Physiol 2007;293:G1124-G1133.
38. LaFramboise WA, Bombach KL, Dhir RJ, Muha N, Cullen RF, Pogozelski AR, et al. Molecular dynamics of the compensatory response to myocardial infarct. J Mol Cell Cardiol 2005;38:103-117.
39. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001;104:487-501.
40. van Dommelen SL, Sumaria N, Schreiber RD, Scalzo AA, Smyth MJ, Degli-Esposti MA. Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity 2006;25:835-848.
41. Trapani JA, Voskoboinik I. The complex issue of regulating perforin expression. Trends Immunol 2007;28:243-245.
42. Szende B, Arvai K, Peták I, Nagy K, Végsǒ. G, Perner F. Changes in gene expression in the course of proliferative processes in the parathyroid gland [in Hungarian]. Magy Onkol 2006; 50:137-140.
43. Saile B, Matthes N, El Armouche H, Neubauer K, Ramadori G. The bcl, NFkappaB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells. Eur J Cell Biol 2001;80:554-561.
44. Kurz EU, Lees-Miller SP. DNA damage-induced activation of ATM and ATM- dependent signaling pathways. DNA Repair (Amst) 2005;3:889-900.
45. Durai R, Yang SY, Seifalian AM, Goldspink G, Winslet MC. Role of insulin-like growth factor binding protein-4 in prevention of colon cancer. World J Surg Oncol 2007;5:128.
46. Sobolevskaia OL, Korochkina OV. Clinical significance of cytokine level and T-cell lymphocyte response to B and C hepatic viral antigens in patients with type C and B+C hepatitis receiving antiviral therapy [in Russian]. Klin Med (Mosk) 2007;85:63-66.
47. Shen X, Hong F, Nguyen VA, Gao B. IL-10 attenuates IFN-alpha-activated STAT1 in the liver: Involvement of SOCS2 and SOCS3. FEBS Lett 2000;480:132-136.
48. Nguyen VA, Gao B. Expression of interferon alfa signaling components in human alcoholic liver disease. HEPATOLOGY 2002;35:425-432.
49. Ajuebor MN, Hogaboam CM, Le T, Proudfoot AE, Swain MG. CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+)T cells to the liver. Eur J Immunol 2004;34:2907-2918.
50. Lee CK, Suh JH, Cho YS, Han KH, Chung JB, Chon CY, et al. Chemokine receptor expression of hepatitis B virus-specific CD8+ lymphocyte in chronic B viral infection. Taehan Kan Hakhoe Chi 2002;8:363-370.
51. Strieter RM, Standiford TJ, Huffnagle GB, Colletti LM, Lukacs NW, Kunkel SL. The good, the bad, and the ugly. The role of chemokines in models of human disease. J Immunol 1996;156:3583-3586.